Sjoerd Zwart, MD, PhD; Alfred Sachs, MD, PhD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Zwart S., Sachs A.; Appropriate Antibiotic Use for Acute Pharyngitis. Ann Intern Med. 2002;136:632-633. doi: 10.7326/0003-4819-136-8-200204160-00018
Download citation file:
Published: Ann Intern Med. 2002;136(8):632-633.
TO THE EDITOR:
We congratulate the Centers for Disease Control and Prevention, the American Academy of Family Physicians, and the American College of Physicians–American Society of Internal Medicine for their clear position paper on antibiotic use for acute pharyngitis in adults (1). These honorable organizations found a good balance between the risks for untreated group A β-hemolytic streptococcal pharyngitis and the risks posed by unnecessary use of antibiotics (side effects, microbial resistance, medicalization).
To our surprise, one recommended treatment strategy appeared to be almost identical to the guidelines in the Netherlands: to refrain from any microbiological test and to limit antibiotic therapy to patients with three or four of the so-called Centor criteria. This suggests that a traditionally strong microbe-oriented approach is gradually shifting toward a more patient-oriented approach. One explanation for this change could be that in many western communities, prevention of acute rheumatic fever is no longer the main reason to administer penicillin because of the low incidence of the condition.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only